rs145712014

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6

The NM_000348.4(SRD5A2):​c.734C>A​(p.Ser245Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.000138 in 1,590,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000090 ( 0 hom. )

Consequence

SRD5A2
NM_000348.4 missense

Scores

3
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 3.81

Publications

5 publications found
Variant links:
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
SRD5A2 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 40 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Trascript score misZ: -0.88748 (below the threshold of 3.09). GenCC associations: The gene is linked to 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency.
BP4
Computational evidence support a benign effect (MetaRNN=0.022504747).
BP6
Variant 2-31526227-G-T is Benign according to our data. Variant chr2-31526227-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436858.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRD5A2
NM_000348.4
MANE Select
c.734C>Ap.Ser245Tyr
missense
Exon 5 of 5NP_000339.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRD5A2
ENST00000622030.2
TSL:1 MANE Select
c.734C>Ap.Ser245Tyr
missense
Exon 5 of 5ENSP00000477587.1

Frequencies

GnomAD3 genomes
AF:
0.000591
AC:
90
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00195
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000200
AC:
43
AN:
215076
AF XY:
0.000165
show subpopulations
Gnomad AFR exome
AF:
0.00169
Gnomad AMR exome
AF:
0.000128
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000211
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000904
AC:
130
AN:
1438136
Hom.:
0
Cov.:
28
AF XY:
0.0000870
AC XY:
62
AN XY:
712946
show subpopulations
African (AFR)
AF:
0.00209
AC:
69
AN:
33008
American (AMR)
AF:
0.000119
AC:
5
AN:
41928
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25510
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39116
South Asian (SAS)
AF:
0.000560
AC:
46
AN:
82118
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52136
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
9.10e-7
AC:
1
AN:
1099018
Other (OTH)
AF:
0.000151
AC:
9
AN:
59552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000591
AC:
90
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.000577
AC XY:
43
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41566
American (AMR)
AF:
0.000196
AC:
3
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68036
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000225
Hom.:
1
Bravo
AF:
0.000714
ESP6500AA
AF:
0.00220
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000274
AC:
33

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:1
Jan 29, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in an individual from a 5-alpha-reductase deficiency cohort, however, it is unknown if this was seen in the homozygous state or with a second SRD5A2 variant (PMID: 32380235); The majority of missense variants in this gene are considered pathogenic (HGMD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 21604088, 32380235, 33469028, 10718838)

3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Benign:1
Oct 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
23
DANN
Benign
0.85
FATHMM_MKL
Uncertain
0.94
D
MetaRNN
Benign
0.023
T
PhyloP100
3.8
PrimateAI
Uncertain
0.55
T
Sift4G
Benign
0.57
T
Vest4
0.44
MVP
0.60
GERP RS
4.9
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145712014; hg19: chr2-31751297; API